Body / AbdominalAI / InformaticsDevices & AI clearances
FDA Clears Aramis Global's AI Renal Assessment Tool (AIRA V1)
U.S. FDA2w ago
The U.S. FDA has cleared the Artificial Intelligence Renal Assessment (AIRA) Version 1, a radiology AI device for renal assessment, via the 510(k) pathway.
- The device is classified under product code QIH (radiological image processing system).
- Cleared via the FDA's 510(k) premarket notification pathway by the Radiology committee.
- Manufacturer: Aramis Global AI Consultancies, LLC.
Automated summary
RadPigeon summaries are original and for information only. They are not clinical advice.